Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene Foam in Acne Vulgaris
NCT01017146Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of tazarotene in acne vulgaris, sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
tazarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01017146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017146.